Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.
Moura FA, Berg DD, Bellavia A, Dwyer JP, Mosenzon O, Scirica BM, Wiviott SD, Bhatt DL, Raz I, Feinberg MW, Braunwald E, Morrow DA, Sabatine MS.
Moura FA, et al. Among authors: sabatine ms.
Diabetes Care. 2023 Oct 1;46(10):1807-1815. doi: 10.2337/dc23-0492.
Diabetes Care. 2023.
PMID: 37556796
Free PMC article.